Vancouver, Canada, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp (www.renaissancebioscience.com), a leader in bioengineering for the global agriculture, animal health, human medicine, and food sector, is pleased to announce its recent patent award from the China patent office. This patent grant, representing the first for its innovative yeast-based platform technology for the production and delivery of RNA bioactive molecules, enhances Renaissance's robust IP portfolio, which includes 50 previous patent awards and 11 pending applications across major global markets.

加拿大温哥华，2023年10月24日（GLOBE NEWSWIRE）-文艺复兴生物科学公司（www.renaissancebioscience.com），全球农业，动物健康，人类医学和食品部门生物工程领导者，很高兴宣布其最近获得中国专利局专利奖。这项专利授予是其创新的基于酵母的平台技术，用于生产和交付RNA生物活性分子的第一项专利授予，增强了文艺复兴时期强大的IP组合，其中包括50项先前的专利授予和11项在全球主要市场上的未决申请。

Given China's status as the world's top pesticide consumer and leading biopesticide producer, this patent award covering the enormous Chinese market is particularly significant. For the full release, click here. This state-of-the-art yeast platform technology is poised to transform the global agriculture industry with its precise, targeted approach to pest control.

鉴于中国作为世界上最大的农药消费国和领先的生物农药生产国的地位，这项涵盖中国巨大市场的专利授予尤为重要。有关完整版本，请单击此处。这种最先进的酵母平台技术有望通过其精确，有针对性的害虫防治方法改变全球农业产业。

Moreover, its implications reach far beyond, with numerous promising applications in animal health and human medicine. Dr. John Husnik, Renaissance’s CSO, shared his enthusiasm: “This groundbreaking patent in China solidifies our position as innovators in the global RNA technology landscape. As our patent portfolio expands, we anticipate tapping into a plethora of opportunities, not just within China but on an international scale.' Key advantages of Renaissance's yeast-based RNA technology include: Stability: Yeast's robust nature ensures RNA molecule protection in varied environments.Manufacturing: Economical, scalable, and quality-driven yeast production means cost-efficient RNA bioactive molecule manufacturing.Adaptability: The platform's versatility supports multiple gene targeting and compound integration, amplifying its app.

此外，其影响范围远远超出，在动物健康和人类医学方面有许多有希望的应用。文艺复兴时期的CSO John Husnik博士，分享他的热情：“中国的这项开创性专利巩固了我们作为全球RNA技术领域创新者的地位。随着我们的专利组合的扩大，我们预计不仅在中国内部，而且在国际范围内都会利用过多的机会。”文艺复兴时期基于酵母的RNA技术的主要优势包括：稳定性：酵母的强大性质确保了var中的RNA分子保护ied环境。制造：经济，可扩展和质量驱动的酵母生产意味着具有成本效益的RNA生物活性分子制造。适应性：平台的多功能性支持多种基因靶向和复合整合，放大其应用程序。